Insider Holders & Insider Ownership - Intellia Therapeutics Inc. (NTLA)

List of insiders holdings for Intellia Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Haurwitz Rachel E.
Director
10% Owner		2016-05-11 18:40:060
5,593,846		5,593,846Form 4
Novartis Institutes for BioMedical Research Inc.
NOVARTIS AG
10% Owner		2021-01-22 16:59:182,176,148
0		2,176,148Form 13D
ORBIMED ADVISORS LLC
OrbiMed Capital GP V LLC
OrbiMed Global Healthcare GP LLC
ISALY SAMUEL D
Director		2018-02-16 13:25:102,113,000
0		2,113,000Form 13D
Caribou Therapeutics Holdco LLC
Caribou Biosciences Inc.
10% Owner		2019-03-25 14:19:401,807,841
0		1,807,841Form 13G
Caribou Biosciences Inc.
10% Owner		2019-03-25 14:19:401,807,841
0		1,807,841Form 13G
Atlas Venture Fund IX L.P.
Atlas Venture Associates IX L.P.
Atlas Venture Associates IX LLC
10% Owner		2019-02-08 06:02:111,615,321
0		1,615,321Form 13G
LEONARD JOHN M
President and CEO		2024-03-05 16:10:121,124,001
58,415		1,182,416Form 4
BAKER BROS. ADVISORS LP
BAKER FELIX
BAKER JULIAN
Baker Bros. Advisors (GP) LLC
Former 10% owner		2016-05-11 16:25:530
976,214		976,214Form 4
Temasek Holdings (Private) Ltd
Fullerton Management Pte Ltd
Temasek Life Sciences Private Ltd
TLS Beta Pte. Ltd.
10% Owner		2016-05-13 06:15:190
790,527		790,527Form 4
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Tananbaum James B.
10% Owner		2016-05-05 18:33:040
613,688		613,688Form 3
Rivera Jose E
EVP, General Counsel		2021-04-02 20:42:02287,594
262,210		549,804Form 4
Bermingham Nessan
President & CEO		2017-12-14 16:07:28292,500
0		292,500Form 4
Srivastava Sapna
Chief Financial & Stategy Offr		2016-05-05 18:38:24291,551
0		291,551Form 3
Bell Graeme
EVP, Chief Financial Officer		2018-03-30 10:20:51223,400
0		223,400Form 4
Lebwohl David
EVP, Chief Medical Officer		2024-03-05 16:10:10148,928
0		148,928Form 4
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer		2024-03-05 16:10:23136,687
0		136,687Form 4
BASTA JAMES
EVP, General Counsel		2024-03-05 16:10:22128,323
0		128,323Form 4
Clark Eliana
EVP, Chief Technical Officer		2024-03-05 16:10:16116,542
0		116,542Form 4
Goddard Glenn
EVP, Chief Financial Officer		2024-03-05 16:10:07110,529
0		110,529Form 4
Hicks Derek
EVP, Chief Business Officer		2024-03-05 16:10:17108,801
0		108,801Form 4
SCHIERMEIER ANDREW
EVP, Chief Operating Officer		2021-03-05 17:53:1591,875
0		91,875Form 4
Barnes Thomas M.
SVP, R&D eXtellia		2017-01-10 20:09:1950,500
0		50,500Form 4
Cohen Fred E
Director		2023-06-16 16:26:0848,189
0		48,189Form 4
Slaoui Moncef
Director		2017-07-25 16:47:2138,000
0		38,000Form 4
Dube Michael P
Principal Accounting Officer		2024-04-22 16:10:0731,223
0		31,223Form 3
Morrissey David V
SVP, Platform & Delivery Tech		2017-01-10 20:11:1230,000
0		30,000Form 4
Heifner Nicole
SVP, Accounting		2017-01-10 20:12:3628,500
0		28,500Form 4
Keresty Georgia
Director		2023-06-16 16:28:4622,619
0		22,619Form 4
CHASE WILLIAM J
Director		2023-06-16 16:30:1821,403
0		21,403Form 4
DORSA CAROLINE
Director		2022-06-16 18:26:4420,389
0		20,389Form 4
HAYES JOHN T.
See Remarks		2018-08-10 16:44:0819,925
0		19,925Form 3
GORDON CARL L
Director		2017-05-19 17:10:2819,000
0		19,000Form 4
Crowley John F
Director		2023-06-16 16:26:5818,189
0		18,189Form 4
GOODMAN JESSE
Director		2023-06-16 16:28:0918,189
0		18,189Form 4
Verwiel Frank
Director		2023-06-16 16:29:3818,189
0		18,189Form 4
FORMELA JEAN FRANCOIS
Director		2022-06-16 18:33:3614,979
0		14,979Form 4
Bhanji Muna
Director		2023-11-02 16:42:5911,996
0		11,996Form 4
KARSEN PERRY A
Director		2020-12-18 16:29:065000
0		5000Form 4